Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.
Clinical trial NCT00500539 · COMPLETED
Trial details
- NCT number
- NCT00500539
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2008-09-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.